Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Real-time measurement of ICD lead motion during stereotactic body radiotherapy of ventricular tachycardia

L. Knybel, J. Cvek, R. Neuwirth, O. Jiravsky, J. Hecko, M. Penhaker, M. Sramko, J. Kautzner

. 2021 ; 26 (1) : 128-137. [pub] 20210225

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018246

Background: Here we aimed to evaluate the respiratory and cardiac-induced motion of a ICD lead used as surrogate in the heart during stereotactic body radiotherapy (SBRT) of ventricular tachycardia (VT). Data provides insight regarding motion and motion variations during treatment. Materials and methods: We analyzed the log files of surrogate motion during SBRT of ventricular tachycardia performed in 20 patients. Evaluated parameters included the ICD lead motion amplitudes; intrafraction amplitude variability; correlation error between the ICD lead and external markers; and margin expansion in the superior-inferior (SI), latero-lateral (LL), and anterior-posterior (AP) directions to cover 90% or 95% of all amplitudes. Results: In the SI, LL, and AP directions, respectively, the mean motion amplitudes were 5.0 ± 2.6, 3.4. ± 1.9, and 3.1 ± 1.6 mm. The mean intrafraction amplitude variability was 2.6 ± 0.9, 1.9 ± 1.3, and 1.6 ± 0.8 mm in the SI, LL, and AP directions, respectively. The margins required to cover 95% of ICD lead motion amplitudes were 9.5, 6.7, and 5.5 mm in the SI, LL, and AP directions, respectively. The mean correlation error was 2.2 ± 0.9 mm. Conclusions: Data from online tracking indicated motion irregularities and correlation errors, necessitating an increased CTV-PTV margin of 3 mm. In 35% of cases, the motion variability exceeded 3 mm in one or more directions. We recommend verifying the correlation between CTV and surrogate individually for every patient, especially for targets with posterobasal localization where we observed the highest difference between the lead and CTV motion.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018246
003      
CZ-PrNML
005      
20210729103945.0
007      
ta
008      
210726s2021 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5603/RPOR.a2021.0020 $2 doi
035    __
$a (PubMed)34046223
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Knybel, Lukas $u Department of Oncology, University Hospital Ostrava, Ostrava, Czech Republic
245    10
$a Real-time measurement of ICD lead motion during stereotactic body radiotherapy of ventricular tachycardia / $c L. Knybel, J. Cvek, R. Neuwirth, O. Jiravsky, J. Hecko, M. Penhaker, M. Sramko, J. Kautzner
520    9_
$a Background: Here we aimed to evaluate the respiratory and cardiac-induced motion of a ICD lead used as surrogate in the heart during stereotactic body radiotherapy (SBRT) of ventricular tachycardia (VT). Data provides insight regarding motion and motion variations during treatment. Materials and methods: We analyzed the log files of surrogate motion during SBRT of ventricular tachycardia performed in 20 patients. Evaluated parameters included the ICD lead motion amplitudes; intrafraction amplitude variability; correlation error between the ICD lead and external markers; and margin expansion in the superior-inferior (SI), latero-lateral (LL), and anterior-posterior (AP) directions to cover 90% or 95% of all amplitudes. Results: In the SI, LL, and AP directions, respectively, the mean motion amplitudes were 5.0 ± 2.6, 3.4. ± 1.9, and 3.1 ± 1.6 mm. The mean intrafraction amplitude variability was 2.6 ± 0.9, 1.9 ± 1.3, and 1.6 ± 0.8 mm in the SI, LL, and AP directions, respectively. The margins required to cover 95% of ICD lead motion amplitudes were 9.5, 6.7, and 5.5 mm in the SI, LL, and AP directions, respectively. The mean correlation error was 2.2 ± 0.9 mm. Conclusions: Data from online tracking indicated motion irregularities and correlation errors, necessitating an increased CTV-PTV margin of 3 mm. In 35% of cases, the motion variability exceeded 3 mm in one or more directions. We recommend verifying the correlation between CTV and surrogate individually for every patient, especially for targets with posterobasal localization where we observed the highest difference between the lead and CTV motion.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cvek, Jakub $u Department of Oncology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Neuwirth, Radek $u MUNI-Masaryk University, Brno, Czech Republic
700    1_
$a Jiravsky, Otakar $u Department of Cardiology, Podlesi Hospital, Trinec, Czech Republic
700    1_
$a Hecko, Jan $u VŠB-Technical University of Ostrava, Ostrava, Czech Republic
700    1_
$a Penhaker, Marek $u VŠB-Technical University of Ostrava, Ostrava, Czech Republic
700    1_
$a Sramko, Marek $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00154188 $t Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology $x 1507-1367 $g Roč. 26, č. 1 (2021), s. 128-137
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34046223 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729103944 $b ABA008
999    __
$a ind $b bmc $g 1676590 $s 1138690
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 1 $d 128-137 $e 20210225 $i 1507-1367 $m Reports of Practical Oncology and Radiotherapy $n Rep Pract Oncol Radiother $x MED00154188
LZP    __
$a Pubmed-20210726

Najít záznam

Citační ukazatele

Možnosti archivace